Sandoz said that it has shipped its first drug to Civica Rx since announcing their partnership in July, which Civica will distribute to its 1,200 U.S. member hospitals.
Sandoz shipped pantoprazole sodium, an injectable drug used to treat adults with astroesophageal reflux disease as well as pathological hypersecretion conditions, including Zollinger-Ellison syndrome.
Sandoz and Civica Rx entered into a five-year agreement in July for Sandoz to supply it with drugs that are commonly in shortage in U.S. hospitals. Civica Rx is a nonprofit organization fighting drug shortages.
Sandoz had said it plans to supply six injectable drugs to Civica Rx, but announced Nov. 2 that it will add a drug used to regulate blood pressure, which has been frequently used to treat COVID-19 patients.
Read the full news release here.
More articles on pharmacy:
FDA reviewers appear to endorse Biogen’s Alzheimer’s drug
Americans have almost doubled spending on specialty drugs from pharmacies, study finds
FDA, FTC warn 2 companies selling faulty COVID-19 treatments
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.